Atlas Trials

Korea United Pharm. Inc.

21 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Korea United Pharm. Inc.

RecordFirmDate
A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers (NCT07682948)Korea United Pharm. Inc.2026-07-01
Safety, PK, and PD Comparison of UI059 and UIC202201 in Healthy Volunteers (NCT07727629)Korea United Pharm. Inc.2026-07-01
A Study to Evaluate the Safety and Pharmacokinetics of UI087 Compared to Coadministration of UIC202506, UIC202507 and UIC202508 in Healthy Adult Volunteers Under Fasting Conditions (NCT07548957)Korea United Pharm. Inc.2026-04-01
A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers (NCT07162441)Korea United Pharm. Inc.2025-08-12
Study to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006" Under Fed Conditions (NCT07691268)Korea United Pharm. Inc.2025-02-13
Bioequivalence Study Between UI009 and UIC202005 in Healthy Subjects (NCT07110740)Korea United Pharm. Inc.2024-10-24
A Study to Compare and Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UI059 and UIC202201 (NCT06393881)Korea United Pharm. Inc.2024-07-03
A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects (NCT06141577)Korea United Pharm. Inc.2023-10-08
Drug-drug Interaction Study Between UIC202304, and UIC202305 (NCT07735052)Korea United Pharm. Inc.2023-09-25
A Clinical Study to Evaluate the Safety and the Pharmacokinetics of UI068 in Healthy Adult Volunteers Under Fed Conditions (NCT06141590)Korea United Pharm. Inc.2023-03-11
Arformoterol/Budesonide for COVID-19 (NCT05055414)Korea United Pharm. Inc.2021-11-01
Study to Evaluate the Safety and PK of UI018 (NCT05085184)Korea United Pharm. Inc.2021-09-06
A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects (NCT05282914)Korea United Pharm. Inc.2021-02-03
A Study to Evaluate the Efficacy and Safety of UI022/UI023 (NCT07600385)Korea United Pharm. Inc.2019-03-12

Track Korea United Pharm. Inc. automatically

Every clearance here is in the API, with alerts when new ones post.